Clinical Trial Update: A Study of CM313 Injection in Subjects With Systemic Lupus Erythematosus [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for CM313 injection in systemic lupus erythematosus across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• CM313

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Systemic Lupus Erythematosus | Phase 1, Phase 2 | Status: UNKNOWN